Supernus Pharmaceuticals | Spese Di Vendita E Di Amministrazione



Selling And Administration Expenses Cambiamento Data
Abbott USD 3.09B 39M 2025-06
ANI Pharmaceuticals USD 81.77M 5.24M 2025-06
Aurora Cannabis CAD 38.18M 2.05M 2024-12
Bristol-Myers Squibb USD 1.71B 129M 2025-06
Canopy Growth CAD 40.62M 308K 2024-12
Corcept Therapeutics USD 103.85M 13.19M 2025-06
Eisai JPY 100.16B 6.34B 2025-06
Eli Lilly USD 2.75B 390.8M 2025-06
Novo Nordisk 18.85B 2.74B 2025-06
Pacira USD 77.19M 9.58M 2025-06
Perrigo USD 273.1M 8.1M 2025-06
Pfizer USD 3.42B 406M 2025-06
Supernus Pharmaceuticals USD 62.22M 27.72M 2025-06
United Therapeutics USD 212.5M 42.4M 2025-06
Xeris Pharmaceuticals USD 80.28M 35.31M 2024-12


Supernus Pharmaceuticals Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.